Literature DB >> 30366683

Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis.

E Michael Lewiecki1, John P Bilezikian2, Lora Giangregorio3, Susan L Greenspan4, Sundeep Khosla5, Paul Kostenuik6, Kelly Krohn7, Michael R McClung8, Paul D Miller9, Roberto Pacifici10.   

Abstract

The Santa Fe Bone Symposium is an annual meeting devoted to clinical applications of recent advances in skeletal research. The 19th Santa Fe Bone Symposium convened August 3-4, 2018, in Santa Fe, New Mexico, USA. Attendees included physicians of many specialties, fellows in training, advanced practice providers, clinical researchers, and bone density technologists. The format consisted of lectures, case presentations by endocrinology fellows, and panel discussions, with all involving extensive interactive discussions. Topics were diverse, including an evolutionary history of calcium homeostasis, osteoporosis treatment in the very old, optimizing outcomes with orthopedic surgery, microbiome and bone, new strategies for combination and sequential therapy of osteoporosis, exercise as medicine, manifestations of parathyroid hormone excess and deficiency, parathyroid hormone as a therapeutic agent, cell senescence and bone health, and managing patients outside clinical practice guidelines. The National Bone Health Alliance conducted a premeeting on development of fracture liaison services. A workshop was devoted to Bone Health TeleECHO (Bone Health Extension for Community Healthcare Outcomes), a strategy of ongoing medical education for healthcare professions to expand capacity to deliver best practice skeletal healthcare in underserved communities and reduce the osteoporosis treatment gap. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECHO; Microbiome; Microbiota; Osteoporosis; Parathyroid

Mesh:

Substances:

Year:  2018        PMID: 30366683     DOI: 10.1016/j.jocd.2018.09.010

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  2 in total

1.  The influence of lactation on BMD measurements and TBS: a 12-month follow-up study.

Authors:  F M F Grizzo; M de Andrade Pereira; L B M Marchiotti; F Guilhem; T da Silva Santos; C M Dell' Agnolo; W A de Melo; M de Medeiros Pinheiro; M D de Barros Carvalho; S M Pelloso
Journal:  Osteoporos Int       Date:  2021-01-21       Impact factor: 4.507

2.  The Effect of a Life-Style Intervention Program of Diet and Exercise on Irisin and FGF-21 Concentrations in Children and Adolescents with Overweight and Obesity.

Authors:  Sofia I Karampatsou; Sofia M Genitsaridi; Athanasios Michos; Eleni Kourkouni; Georgia Kourlaba; Penio Kassari; Yannis Manios; Evangelia Charmandari
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.